Hilton Continues French Focused Service Expansion
Having announced the launch of its focused service Hilton Garden Inn and Hampton by Hilton brands in France at last year’s MIPIM conference in Cannes, Hilton (NYSE: HLT) is continuing to expand in the French mid-market segment with two new properties.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180312005738/en/
Hilton Garden Inn Massy (Photo: Business Wire)
The group has signed a Hilton Garden Inn hotel to open in the Parisian suburb of Massy and a Hampton by Hilton property near Toulouse Airport under franchise agreements with Naos Hôtel Groupe and NT Hotel Gallery respectively.
Patrick Fitzgibbon, senior vice president, development, EMEA, Hilton, said: “Both of these new projects support our drive to grow our portfolio in France by introducing new brands at key transport hubs. Last year Toulouse Airport received 1.1 million more passengers than in 2016, a record increase, while the Massy train station complex has direct links to Nantes, Lyon, Marseille, Grenoble, Toulouse and Strasburg. These important hubs will be strong demand drivers for these two quality developments.”
Hilton Garden Inn Massy
The hotel will form part of a mixed-use development also comprising residential and retail space, along with a cinema and congress centre. The property is adjacent to the main train station, which welcomes France’s intercity high-speed rail (TGV) and has a direct metro line into central Paris, connecting the hotel to major French cities and Paris city centre. The 152 guest-room property will be marked by a distinctive geometric tower designed by world-renowned architect Christian de Portzamparc.
Pascal Lemarchand, CEO, Naos Hôtel Groupe, said: “Having partnered with Hilton with the announcement of three hotels last year, our intention was to develop this relationship and roll out additional properties under its brands. Hilton Garden Inn Massy will form a focal part of the redevelopment of Massy and we look forward to welcoming guests next summer.”
Hilton Garden Inn Massy will be located on Avenue Carnot / Place du Grand Ouest. 91300, Massy.
Hampton by Hilton Toulouse Airport
At just 600m from the airport terminal and 800m from Blagnac Shopping Centre, Hampton by Hilton Toulouse Airport will provide a convenient new option for passengers travelling through Toulouse. The hotel will have 126 guest-rooms, a fitness centre, work zone and a grab-and-go F&B offering.
Nicolas Andrieu, NT Hotel Gallery, said: “We are pleased to be bringing a Hilton branded hotel to the city of Toulouse for the very first time. As a leading international brand, Hampton by Hilton connects us to an audience of seasoned international air travellers and in particular a loyalty base of more than 71 million Hilton Honors guests. We look forward to welcoming these visitors to Toulouse.”
Hampton by Hilton Toulouse Airport will be located at 92 rue Bordebasse, Blagnac.
Hilton currently operates nine hotels in France under three brands. It is set to more than double its presence in the market with a pipeline of 14 properties, and this year is due to introduce two brands with the opening of Hilton Garden Inn Bordeaux Centre Gare and Hampton by Hilton Paris Clichy. Both hotels will be operated by Naos Hôtel Groupe.
Hilton (NYSE: HLT) is a leading global hospitality company, with a portfolio of 14 world-class brands comprising more than 5,200 properties with more than 856,000 rooms, in 105 countries and territories. Hilton is dedicated to fulfilling its mission to be the world’s most hospitable company by delivering exceptional experiences – every hotel, every guest, every time. The company's portfolio includes Hilton Hotels & Resorts, Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Canopy by Hilton, Curio Collection by Hilton, DoubleTree by Hilton, Tapestry Collection by Hilton, Embassy Suites by Hilton, Hilton Garden Inn, Hampton by Hilton, Tru by Hilton, Homewood Suites by Hilton, Home2 Suites by Hilton and Hilton Grand Vacations. The company also manages an award-winning customer loyalty program, Hilton Honors. Hilton Honors members who book directly through preferred Hilton channels have access to instant benefits, including a flexible payment slider that allows members to choose exactly how many Points to combine with money, an exclusive member discount that can’t be found anywhere else, and free standard Wi-Fi. Visit newsroom.hilton.com for more information and connect with Hilton on Facebook, Twitter, LinkedIn, Instagram, and YouTube.
About Hilton Garden Inn
The award-winning Hilton Garden Inn brand provides business and leisure guests with upscale yet affordable accommodations and modern amenities for a successful and comfortable stay. The satisfaction promise affirms the brand’s goal to make each stay better and brighter. Guaranteed. As a recognized F&B leader, Hilton Garden Inn serves daily cooked-to-order breakfast and offers full service restaurants and bars. Team Members at more than 770 hotels around the world are committed to guaranteeing today’s busy travelers have a bright and satisfying experience from the first hello when they arrive. Hilton Garden Inn is part of Hilton Honors, the award-winning guest loyalty program for Hilton’s 14 distinct hotel brands. Hilton Honors members who book directly through preferred Hilton channels have access to instant benefits, including a flexible payment slider that allows members to choose nearly any combination of Points and money to book a stay, an exclusive member discount that can’t be found anywhere else, free standard Wi-Fi and digital amenities like digital check-in with room selection and Digital Key (select locations), available exclusively through the industry-leading Hilton Honors app. For more information about Hilton Garden Inn, visit www.hgi.com or news.hgi.com or connect on social media at Facebook, Twitter, YouTube, and Instagram.
About Hampton by Hilton
As the number one ranked lodging franchise for the past nine years, according to Entrepreneur®, Hampton by Hilton, including Hampton Inn by Hilton and Hampton Inn & Suites by Hilton, serves value-conscious and quality-driven travelers with more than 2,330 properties and more than 237,000 rooms in 21 countries and territories. High quality accommodations and amenities, such as complimentary Wi-Fi, free hot breakfast and On The RunTM breakfast bags, contribute to Hampton by Hilton ranking as a leader in its segment. Hampton by Hilton Team Members deliver friendly, authentic, caring and thoughtful service defined as Hamptonality. Each Hampton by Hilton hotel offers complete satisfaction with the 100% Hampton® Guarantee. Hampton by Hilton is part of Hilton Honors, the award-winning guest loyalty program for Hilton’s 14 distinct hotel brands. Hilton Honors members who book directly through preferred Hilton channels have access to instant benefits, including a flexible payment slider that allows members to choose nearly any combination of Points and money to book a stay, an exclusive member discount that can’t be found anywhere else, free standard Wi-Fi and digital amenities like digital check-in with room selection and Digital Key (select locations), available exclusively through the industry-leading Hilton Honors app. For more information about Hampton by Hilton, visit www.hampton.com or news.hampton.com and connect online at Facebook, Twitter, YouTube and Instagram.
+44 207 856 8005
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Celltrion Completes Resubmission to FDA for Proposed Trastuzumab Biosimilar18.6.2018 05:53 | Tiedote
Celltrion (KRX:068270) has made a resubmission to the FDA (U.S. Food and Drug Administration) to obtain its marketing approval for CT-P6, a proposed mAb biosimilar to Herceptin® (trastuzumab). Celltrion submitted its abbreviated Biologics License Applications (aBLAs) for CT-P10 and CT-P6 to the FDA in April and May of last year, respectively. However, it received CRLs (complete response letters) from the FDA related to the warning letter issued by the FDA in January 2018, related to the manufacturing facility in Incheon, South Korea. Celltrion had completed the resubmission for the approval of CT-P10, a proposed biosimilar to Rituxan® (rituximab) last month. In accordance with FDA regulations, the approval procedure will be usually finalized within six months from the resubmission, so Celltrion expects the approval for the U.S. market of the two proposed biosimilars within this calendar year. FDA has notified Celltrion of its re-inspection schedule regarding regular audit results, and
CES Asia: Innovation at the Speed of 5G15.6.2018 17:59 | Tiedote
CES Asia® 2018 wrapped today with the rapid pace of global innovation front and center over the show’s three day duration. The next stage of technology advancements were showcased across vehicle tech, robotics, artificial intelligence (AI), virtual and augmented reality, digital health and more. The event, 24 percent larger than last year in terms of footprint, cemented itself as the place to fully experience how the pace of technology is accelerating globally. CES Asia, the premier event for tech innovation in the Asian marketplace, will return to Shanghai, China, June 11-13, 2019. “5G and AI are igniting growth across the entire tech ecosystem changing the way we interact with technology and the world around us,” said Gary Shapiro, president and CEO, Consumer Technology Association (CTA)™. “It’s incredible to see technology refining and reinventing itself at such a fast pace. Just six months ago we were at CES with life-altering tech all around us. This week, I saw that technology re
bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobin™ Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association15.6.2018 13:00 | Tiedote
bluebird bio, Inc. (Nasdaq: BLUE) today announced new interim data from the ongoing HGB-206 Phase 1 multicenter clinical study of LentiGlobin investigational gene therapy in patients with severe sickle cell disease (SCD) will be presented in an oral presentation on Saturday, June 16 at the 23rd Congress of the European Hematology Association (EHA) by Julie Kanter, M.D., Medical University of South Carolina, Charleston, South Carolina. “The consistent production of increased amounts of anti-sickling HbAT87Q in the Group C patients reflects the substantial positive impact of the changes introduced with the amended HGB-206 study protocol and refined manufacturing process. All four Group C patients with greater than or equal to three months follow-up are making over 30 percent anti-sickling HbAT87Q. The first patient treated, now with six months of follow-up, is producing over 60 percent anti-sickling HbAT87Q with a normal total hemoglobin level of 14.2 g/dL,” said David Davidson, M.D., ch
bluebird bio Presents New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin™ Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia at Annual Congress of the European Hematology Association15.6.2018 13:00 | Tiedote
bluebird bio, Inc. (Nasdaq: BLUE) announced that new data from the completed Phase 1/2 Northstar (HGB-204) study in adolescents and adults with transfusion-dependent β-thalassemia (TDT) and any genotype, and its ongoing, Phase 3 Northstar-2 (HGB-207) multicenter clinical study of LentiGlobin™ investigational gene therapy in patients with TDT and non-β0/β0 genotypes, will be presented in an oral session on June 16 at the 23rd Annual Congress of the European Hematology Association by Franco Locatelli, M.D., Ph.D., of the IRCCS Ospedale Pediatrico Bambino Gesù of Rome, Italy. “The maturing data from HGB-204 and HGB-207 suggest that one-time treatment with LentiGlobin may address the underlying genetic cause of TDT. With our refined manufacturing process, the majority of patients with TDT and non-β0/β0 genotypes are transfusion-free and producing total hemoglobin at normal or near-normal levels,” said David Davidson, M.D., chief medical officer, bluebird bio. “We are on track to submit a m
AGP Group Announces the Acquisition of Soliver NV in Belgium, Representing a Key Step towards Becoming the Premier Global Leader in Designing and Manufacturing High-Tech Automotive Glazing15.6.2018 12:00 | Tiedote
AGP, a high-tech specialty glass designer and manufacturer, has announced today the acquisition of Soliver NV, a European automotive glazing manufacturer with over 65 years of solid product and brand reputation. Soliver offers high-quality tempered and laminated glazing for high-end automobiles, as well as windshield solutions for trucks. AGP’s glazing heritage started in Berlin, with the Mannheim family´s first glass company. After 100 years and a clear vision to become a leader in specialty glass, AGP’s core eGlass technologies have responded to the rising demand in electrification, connectivity, shared mobility and autonomous driving, acting as an enabler of future mobility trends. The integration of Soliver into the AGP Group will strengthen the AGP eGlass value proposition and will be a game changer in a fast-evolving industry. “We are very excited to build upon Soliver’s great experience and track-record to take high-tech glazing to the next level, enabling our customer’s product
Rivoli Group announces completion of its new international corporate strategy15.6.2018 10:00 | Tiedote
Rivoli Group AG completes its comprehensive operational restructuring process and acts with a new presence in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180615005085/en/ Rivoli Group Announces Completion of Its New International Corporate Strategy (Photo: Business Wire) The Swiss based Rivoli Group AG has now completed the comprehensive restructuring process as part of the international realignment of its corporate strategy. After an intensive evaluation of the situation, the available resources and existing market potential, the Chairman of the Board of Directors Mr. Mourad Malloul, the management team and an international advisory committee coordinated the strategy together. "This is the beginning of a crucial new chapter for the Rivoli Group," the President and CEO of Rivoli Group AG said. The measure aims to strengthen the competitive advantages within the company group, to adjust their service offerings
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme